DaVita: 25 Years of Exceptional Patient Care and Empowering the Future of Kidney Health

DaVita, a leading kidney care provider, is celebrating its 25th anniversary with a remarkable track record of clinical excellence, innovation, and commitment to improving lives. Since its inception in 2000, DaVita has focused on delivering high-quality, patient-centered care, fostering an inclusive workforce, and building strong community partnerships. As the company looks ahead to the next 25 years, it continues to push boundaries to create better outcomes for patients, physician partners, and teammates.



DaVita's steadfast commitment to patient-centered care has driven its success. The company has consistently improved clinical outcomes, enhanced quality of life for patients, and expanded access to care through value-based care arrangements, home care, and transplantation programs. DaVita's integrated kidney care model, which combines dialysis services with preventive care and chronic disease management, has proven effective in slowing disease progression and reducing healthcare costs.

One notable achievement is DaVita's participation in the government's voluntary Kidney Care Choices (KCC) model, the largest government model for kidney care. In the first performance year, DaVita and its nephrologist partners achieved a 16% industry increase in optimal start rates for kidney patients transitioning to dialysis. This reduction in unplanned starts leads to more optimal outcomes for patients, with care teams better coordinating their kidney and non-kidney care needs and improving interventions to help keep them healthy and out of the hospital, while also reducing high healthcare costs.



DaVita's global expansion has also played a significant role in its growth and financial performance. With operations in 14 countries, including recent expansions in Brazil, Colombia, Chile, Ecuador, and Japan, DaVita has increased its patient base and diversified its revenue streams. The company's commitment to sustainability is evident in its progress toward 100% renewable energy usage globally, following its achievement of this goal in the U.S. in 2021.



Investors can capitalize on future international opportunities in kidney care by considering DaVita's growth strategies and the growing demand for kidney care services worldwide. As the global prevalence of chronic kidney disease (CKD) increases, driven by factors such as aging populations, diabetes, and hypertension, DaVita's expertise and resources position it well to capture market share in new regions.

In conclusion, DaVita's 25-year journey is a testament to its commitment to patient-centered care, innovation, and empowering the future of kidney health. As the company looks ahead to the next 25 years, investors can expect DaVita to continue pushing boundaries, driving clinical excellence, and delivering value to its stakeholders. By investing in DaVita, investors can participate in the growth and success of a leading kidney care provider with a proven track record and a bright future.